Mahajan Imaging Introduces Blood Biomarker Test

Mahajan Imaging and Labs on Jan. 20, 2026 introduced an AI-integrated pTAU/Aβ1-42 blood biomarker test combined with structured PET and MRI pathways, the company said at a Gurugram symposium. The test, approved by the US FDA and India's CDSCO, aims to expand early Alzheimer's detection in India where amyloid PET scans can cost up to Rs 2 lakh. Conclusions will be shared with the Neurological Society of India to inform guidelines.